329 related articles for article (PubMed ID: 31379831)
1. Lytic Susceptibility, Structure, and Mechanical Properties of Fibrin in Systemic Lupus Erythematosus.
Litvinov RI; Nabiullina RM; Zubairova LD; Shakurova MA; Andrianova IA; Weisel JW
Front Immunol; 2019; 10():1626. PubMed ID: 31379831
[TBL] [Abstract][Full Text] [Related]
2. The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis.
Collet JP; Moen JL; Veklich YI; Gorkun OV; Lord ST; Montalescot G; Weisel JW
Blood; 2005 Dec; 106(12):3824-30. PubMed ID: 16091450
[TBL] [Abstract][Full Text] [Related]
3. Impaired contraction of blood clots as a novel prothrombotic mechanism in systemic lupus erythematosus.
Le Minh G; Peshkova AD; Andrianova IA; Sibgatullin TB; Maksudova AN; Weisel JW; Litvinov RI
Clin Sci (Lond); 2018 Jan; 132(2):243-254. PubMed ID: 29295895
[TBL] [Abstract][Full Text] [Related]
4. Structure, Mechanical, and Lytic Stability of Fibrin and Plasma Coagulum Generated by Staphylocoagulase From
Farkas ÁZ; Farkas VJ; Szabó L; Wacha A; Bóta A; Csehi L; Kolev K; Thelwell C
Front Immunol; 2019; 10():2967. PubMed ID: 31921206
[No Abstract] [Full Text] [Related]
5. Interpretation and Validation of Maximum Absorbance Data Obtained from Turbidimetry Analysis of Plasma Clots.
Pieters M; Guthold M; Nunes CM; de Lange Z
Thromb Haemost; 2020 Jan; 120(1):44-54. PubMed ID: 31752041
[TBL] [Abstract][Full Text] [Related]
6. DNA and histones impair the mechanical stability and lytic susceptibility of fibrin formed by staphylocoagulase.
Komorowicz E; Farkas VJ; Szabó L; Cherrington S; Thelwell C; Kolev K
Front Immunol; 2023; 14():1233128. PubMed ID: 37662916
[TBL] [Abstract][Full Text] [Related]
7. Enhanced lysis and accelerated establishment of viscoelastic properties of fibrin clots are associated with pulmonary embolism.
Martinez MR; Cuker A; Mills AM; Crichlow A; Lightfoot RT; Chernysh IN; Nagaswami C; Weisel JW; Ischiropoulos H
Am J Physiol Lung Cell Mol Physiol; 2014 Mar; 306(5):L397-404. PubMed ID: 24414255
[TBL] [Abstract][Full Text] [Related]
8. Recombinant fibrinogen reveals the differential roles of α- and γ-chain cross-linking and molecular heterogeneity in fibrin clot strain-stiffening.
Piechocka IK; Kurniawan NA; Grimbergen J; Koopman J; Koenderink GH
J Thromb Haemost; 2017 May; 15(5):938-949. PubMed ID: 28166607
[TBL] [Abstract][Full Text] [Related]
9. Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen.
Hugenholtz GC; Macrae F; Adelmeijer J; Dulfer S; Porte RJ; Lisman T; Ariëns RA
J Thromb Haemost; 2016 May; 14(5):1054-66. PubMed ID: 26833718
[TBL] [Abstract][Full Text] [Related]
10. Thyroid dysfunction and fibrin network structure: a mechanism for increased thrombotic risk in hyperthyroid individuals.
Hooper JM; Stuijver DJ; Orme SM; van Zaane B; Hess K; Gerdes VE; Phoenix F; Rice P; Smith KA; Alzahrani SH; Standeven KF; Ajjan RA
J Clin Endocrinol Metab; 2012 May; 97(5):1463-73. PubMed ID: 22378816
[TBL] [Abstract][Full Text] [Related]
11. The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease.
Neergaard-Petersen S; Hvas AM; Kristensen SD; Grove EL; Larsen SB; Phoenix F; Kurdee Z; Grant PJ; Ajjan RA
Thromb Haemost; 2014 Dec; 112(6):1142-50. PubMed ID: 25187394
[TBL] [Abstract][Full Text] [Related]
12. Contact activation products are new potential biomarkers to evaluate the risk of thrombotic events in systemic lupus erythematosus.
Bäck J; Lood C; Bengtsson AA; Ekdahl KN; Nilsson B
Arthritis Res Ther; 2013; 15(6):R206. PubMed ID: 24299152
[TBL] [Abstract][Full Text] [Related]
13. Unfavorably Altered Fibrin Clot Properties in Patients with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Association with Thrombin Generation and Eosinophilia.
Mastalerz L; Celińska-Lӧwenhoff M; Krawiec P; Batko B; Tłustochowicz W; Undas A
PLoS One; 2015; 10(11):e0142167. PubMed ID: 26540111
[TBL] [Abstract][Full Text] [Related]
14. Altered fibrin clot structure/function in patients with antiphospholipid syndrome: association with thrombotic manifestation.
Celińska-Lowenhoff M; Iwaniec T; Padjas A; Musiał J; Undas A
Thromb Haemost; 2014 Aug; 112(2):287-96. PubMed ID: 24652596
[TBL] [Abstract][Full Text] [Related]
15. Blood clot contraction differentially modulates internal and external fibrinolysis.
Tutwiler V; Peshkova AD; Le Minh G; Zaitsev S; Litvinov RI; Cines DB; Weisel JW
J Thromb Haemost; 2019 Feb; 17(2):361-370. PubMed ID: 30582674
[TBL] [Abstract][Full Text] [Related]
16. BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes.
Greenhalgh KA; Strachan MW; Alzahrani S; Baxter PD; Standeven KF; Storey RF; Ariens RA; Grant PJ; Price JF; Ajjan RA
Thromb Haemost; 2017 Jan; 117(2):295-302. PubMed ID: 27929198
[TBL] [Abstract][Full Text] [Related]
17. Increased fibrin polymerization rate in patients with primary antiphospholipid syndrome and systemic lupus erythematosus.
de Pablo P; Ramírez A; Cortina E; de la Peña A; Zamora J; Izaguirre R; Amigo MC
Clin Appl Thromb Hemost; 2003 Jul; 9(3):221-5. PubMed ID: 14507110
[TBL] [Abstract][Full Text] [Related]
18. Effects of Diabetes Mellitus on Fibrin Clot Structure and Mechanics in a Model of Acute Neutrophil Extracellular Traps (NETs) Formation.
de Vries JJ; Hoppenbrouwers T; Martinez-Torres C; Majied R; Özcan B; van Hoek M; Leebeek FWG; Rijken DC; Koenderink GH; de Maat MPM
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993159
[TBL] [Abstract][Full Text] [Related]
19. Recurrent venous thromboembolism patients form clots with lower elastic modulus than those formed by patients with non-recurrent disease.
Baker SR; Zabczyk M; Macrae FL; Duval C; Undas A; Ariëns RAS
J Thromb Haemost; 2019 Apr; 17(4):618-626. PubMed ID: 30725502
[TBL] [Abstract][Full Text] [Related]
20. Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia.
Sauls DL; Wolberg AS; Hoffman M
J Thromb Haemost; 2003 Feb; 1(2):300-6. PubMed ID: 12871504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
